4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000921895-24-002631
See Explanation of Responses disposed of 5,680,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL See Explanation of Responses | 2024-11-08 | Other disposition | −3,062,000 | 830,237 | D | ||
| BVF PARTNERS L P/IL See Explanation of Responses | 2024-11-08 | Other disposition | −2,378,000 | 662,970 | D | ||
| BVF PARTNERS L P/IL See Explanation of Responses | 2024-11-08 | Other disposition | −240,000 | 87,911 | D | ||
| Derivatives | |||||||
| BVF PARTNERS L P/IL See Explanation of Responses | 2024-11-08 | Other acquisition · Pre-Funded Warrant | +3,062,000 | 3,062,000 | D | ||
| BVF PARTNERS L P/IL See Explanation of Responses | 2024-11-08 | Other acquisition · Pre-Funded Warrant | +2,378,000 | 2,378,000 | D | ||
| BVF PARTNERS L P/IL See Explanation of Responses | 2024-11-08 | Other acquisition · Pre-Funded Warrant | +240,000 | 240,000 | D | ||
Loading xslF345X05/form407422010_11132024.xml…